This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cosette Pharmaceuticals, Inc. By combining Cosettes strong portfolio with Mayne Pharmas proven commercial expertise, the combined company will be well positioned to further invest in innovation, portfolio expansion and better serve our patients. is acquiring Mayne Pharma.
In an industry racing toward innovation and obsessed with results, theres a rare breed of skincare brand that manages to balance clinical-grade technology with the power of plants. Weve been singing Sesha Skin Therapy s praises for yearsand for good reason. Thanks to Sesha Skin Therapy for sponsoring this content.
Phyllis Hsieh is the visionary behind Conrex Pharmaceutical Corp. and the creator of SESHA SKIN THERAPY, a professional skincare brand powered by Patented enhancement technology (P.E.T ) technology. Her commitment to innovation and quality has solidified SESHA’s reputation as a trusted leader in professional skincare worldwide.
Tildrakizumab-asmn (Ilumya, Sun Pharmaceutical Industries, Inc.) “As a company dedicated to developing innovativetherapies which help improve quality of life for patients, these data, along with our existing data in scalp psoriasis, reinforces the benefits of ILUMYA in difficult to treat populations.”
Scientific research has contributed to the development of innovative delivery systems designed to address a range of skin issues around the eyes. Our esthetics, massage therapy, and make up students study the history of beauty culture through the ages. Contains 90% Green Tea Polyphenols – the highest percentage synthesized effectively.
In this era of readily available pharmaceutical products for every imaginable ailment, it can be easy to default to the drug store when we need relief. Medieval Persian pharmaceutical manuscripts refer to 1200 types of oxymel. It has not always been that way. Reposted from: [link]
GLP-1’s unique ability to affect both glucose metabolism and appetite makes it a critical hormone in weight management and a target for pharmaceutical treatments aimed at curbing hunger and improving metabolic health. At the same time, GLP-1 signals to the brain that the stomach is full, helping to suppress appetite.
Nicholas Norwitz, a Harvard medical student who holds a doctorate in metabolism and nutrition from the University of Oxford, has explored uncharted territory in cholesterol management through an innovative experiment. percent reduction—on statin therapy.
Alys Pharmaceuticals, Inc. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. ” The post Get to Know Alys Pharmaceuticals, Inc. appeared first on The Dermatology Digest.
This is the] reason why the development of new strategies, including the chemical modification of carnosine or its vehiculation into innovative drug delivery systems (DDS), aiming at increasing its bioavailability and/or at facilitating the site-specific transport to different tissues, is of utmost importance.”
A cosmeceutical is essentially a skincare product that contains a biologically active compound that is thought to have pharmaceutical effects on the skin. Both pharmaceutical and cosmeceutical grade skin care products actively effect skin at a cellular level, whereas cosmetic products have a shorter-term effect.
Dinkov also reviews groundbreaking research and innovative treatments that aim to manipulate cellular energy pathways to combat cancer. Vitamins and Cancer Metabolism Dinkov also discusses the findings of experimental studies he’s involved in, in which they’re using vitamins and pharmaceutical agents to target the metabolism of cancer cells.
As a result, treatment with some of these new, innovative immune therapies used in oncology may “tilt the teeter-totter of your immune system into a dangerous place of overreactivity,” she says, adding “For a $12, paid-out-of-your-pocket, walk-in lab test, you get a really good sense of where your immune system lies.”
In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc.,
Some researchers are looking for innovative ways to fight cancer. According to a 2021 study published in Advanced Pharmaceutical Bulletin (APB), epidemiological evidence shows a clear link between fungal infections and cancer development. One novel approach may involve addressing fungal infections.
Groundbreaking Topics + Global Experts Among the standout sessions was an exploration of testosterone therapy for men and perimenopausal women , discussing its safety, efficacy, and its expanding role in aesthetic and wellness medicine. View this post on Instagram A post shared by Dr. Vincent Wong (@drvincentwong)
Rosenberg, MD, is Verrica Pharmaceuticals Inc.s Dr. Rosenberg led the clinical development and approval of Xepi, a topical antibiotic for the treatment of impetigo, at Medimetriks Pharmaceuticals. Rosenberg Named New CMO at Verrica Pharmaceuticals appeared first on The Dermatology Digest. new Chief Medical Officer (CMO).
With over two decades as a beauty therapist and chemist, Jacine has become an industry innovator, winning multiple international awards and earning global recognition. This dual mechanismantimicrobial and anti-inflammatorymakes Magnolia officinalis a paradigm shift in acne therapy.
From LED light therapy and microneedling to microcurrent, laser treatments, and infrared saunas , these advanced modalities are now essential in aesthetic practices. Dr. Vincent works closely with major pharmaceutical companies in the field as a Global Advisor and lectures internationally.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content